Cardiovascular Effectiveness Of Sglt-2 Inhibitors Versus Metformin As First-Line Treatment For Type 2 DiabetesHojin Shin,Sebastian Schneeweiss,Robert Glynn,Elisabetta PatornoPHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2021)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要